Recurrent Acute Biphenotypic Leukemia Recruiting Phase 1 / 2 Trials for Quizartinib (DB12874)
Also known as: Acute, recurrent Biphenotypic Leukemia
| Indication | Status | Phase |
|---|---|---|
| DBCOND0106027 (Recurrent Acute Biphenotypic Leukemia) | Recruiting | 1 / 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT04047641 | Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome | Treatment |